WeVote

Bill

Bill

SF 4601

Menstrual products ingredient disclosure requirement

2025-2026 Regular Session Introduced by Julia Coleman and 1 co-sponsor

The bill would require menstrual products sold in Minnesota to disclose ingredient lists, increasing consumer transparency and safety information.

Referred to Commerce and Consumer Protection
0
WeVote Research Nonpartisan
Bill Summary · SF 4601

Summary — Minnesota Senate File (SF) 4601 (2025-2026)

Title

Menstrual products ingredient disclosure requirement

Overview

SF 4601 would require certain menstrual products to disclose ingredients or ingredients of concern. The bill aims to increase transparency for consumers by mandating ingredient labeling or disclosure where menstrual products are sold or offered for sale.

Purpose and intent

  • Enhance consumer information and protection by ensuring that essential ingredients in menstrual products are disclosed.
  • Provide transparency around ingredients that may raise safety, allergen, or environmental concern.
  • Align with broader public health and consumer-right-to-know objectives by clarifying labeling expectations for menstrual products sold in Minnesota.

Key provisions (proposed by SF 4601)

  • Scope: Applies to menstrual products offered for sale to Minnesota consumers. (General intent; exact product categories may include items such as pads, tampons, liners, and similar absorbent products, depending on the bill’s text.)
  • Disclosure requirement: Manufacturers, distributors, or retailers would be required to disclose ingredients or ingredient lists. This could entail:
    • Labeling on product packaging.
    • Availability of an ingredient list via a point-of-sale display, packaging insert, or an accessible online resource.
  • Ingredient standards: The bill would identify that ingredients or substances in menstrual products must be disclosed. It may specify that ingredients of concern (e.g., fragrances, certain polymers, dyes, or preservatives) be listed, though the exact list or categories would be defined in the bill’s text.
  • Enforcement mechanism: Provisions likely establish enforcement by a state agency (commonly the Minnesota Department of Commerce or a consumer protection agency) and may authorize penalties or corrective actions for non-compliance.
  • Effective date: The bill would specify when the disclosure requirement takes effect (e.g., upon enactment or after a defined transition period).
  • Penalties and remedies: Potential civil penalties, administrative actions, or corrective measures for violations. Possible consumer redress mechanisms.

Who is affected

  • Manufacturers, distributors, and retailers of menstrual products sold in Minnesota.
  • Suppliers and online sellers shipping to Minnesota if their products are available to Minnesota consumers.
  • Potentially, third-party sellers and marketplace platforms that list menstrual products for sale in Minnesota.

Procedural and timeline aspects

  • Introduction and first reading on 2026-03-18.
  • Referred to Committee: Commerce and Consumer Protection (as of 2026-03-18).
  • Next steps would typically include committee hearings, possible amendments, and passage by the Minnesota Senate before moving to the House (and then to the governor for signature). The exact timetable depends on committee action and legislative scheduling.

Potential impact and considerations

  • Consumer empowerment through accessible ingredient information.
  • Possible cost impact on manufacturers and retailers to compile and present ingredient disclosures.
  • Clarity for consumers with allergies or sensitivities seeking to avoid certain substances.
  • Administrative and enforcement considerations for state agencies, including monitoring compliance and handling complaints.

Note: The summary reflects the bill’s title and the action history available. The precise language, including the exact scope, definition of ingredients, disclosure format, and enforcement details, would appear in the bill’s full text.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.